Aptevo Therapeutics Stock Price on November 18, 2024
| APVO Stock | USD 0.28 0.06 17.65% |
Below is the normalized historical share price chart for Aptevo Therapeutics extending back to July 20, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aptevo Therapeutics stands at 0.28, as last reported on the 3rd of December, with the highest price reaching 0.35 and the lowest price hitting 0.28 during the day.
If you're considering investing in Aptevo Stock, it is important to understand the factors that can impact its price. Aptevo Therapeutics appears to be extremely dangerous, given 3 months investment horizon. Aptevo Therapeutics secures Sharpe Ratio (or Efficiency) of 0.028, which signifies that the company had a 0.028% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aptevo Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Aptevo Therapeutics' Risk Adjusted Performance of 0.0331, downside deviation of 11.9, and Mean Deviation of 7.99 to double-check if our risk estimates are consistent with your expectations.
At this time, Aptevo Therapeutics' Common Stock Shares Outstanding is very stable compared to the past year. As of the 3rd of December 2024, Stock Based Compensation is likely to grow to about 2.2 M, while Total Stockholder Equity is likely to drop about 11.6 M. . As of the 3rd of December 2024, Price To Sales Ratio is likely to drop to 4.17. In addition to that, Price Earnings Ratio is likely to drop to -0.13. Aptevo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of July 2016 | 200 Day MA 1.3536 | 50 Day MA 0.2285 | Beta 5.066 |
Aptevo |
Sharpe Ratio = 0.028
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | APVO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.3 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.35 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Aptevo Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptevo Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.9943 | Enterprise Value Ebitda 0.3863 | Price Sales 1.6074 | Shares Float 17.5 M | Wall Street Target Price 8 |
Related Headline
Larimar Therapeutics Headline on 18th of November 2024
Larimar Therapeutics Presents Additional Data from Phase 1 S... by finance.yahoo.com
Treatment with nomlabofusp modified gene expression and lipid profiles in addition to increasing frataxin levels in study participants with Friedreichs ataxia Modeling and simulation predict that, in most patients with FA, 50 mg of nomlabofusp administered daily is likely to achieve FXN levels that are 50 percent of levels observed in healthy controls and similar to mean FXN levels reported in asymptomatic heterozygous carriers Disease characteristics of adult participants in the nomlabofus
Aptevo Therapeutics Valuation on November 18, 2024
It is possible to determine the worth of Aptevo Therapeutics on a given historical date. On November 18, 2024 Aptevo was worth 0.22 at the beginning of the trading date compared to the closed value of 0.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aptevo Therapeutics stock. Still, in general, we apply an absolute valuation method to find Aptevo Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aptevo Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aptevo Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.24 | 0.24 | 0.21 | 0.21 | 768,198 | |
11/18/2024 | 0.22 | 0.22 | 0.20 | 0.22 | 1,047,685 |
| 0.23 | 0.25 | 0.22 | 0.25 | 1,350,612 |
| Backtest Aptevo Therapeutics | | | Aptevo Therapeutics History | | | Aptevo Therapeutics Valuation | Previous | Next |
Aptevo Therapeutics Trading Date Momentum on November 18, 2024
| On November 19 2024 Aptevo Therapeutics was traded for 0.25 at the closing time. The top price for the day was 0.25 and the lowest listed price was 0.22 . The trading volume for the day was 1.4 M. The trading history from November 19, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 13.64% . The overall trading delta against the current closing price is 54.55% . |
Aptevo Therapeutics Fundamentals Correlations and Trends
By evaluating Aptevo Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aptevo Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aptevo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aptevo Therapeutics Stock history
Aptevo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aptevo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aptevo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aptevo Therapeutics stock prices may prove useful in developing a viable investing in Aptevo Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 278.1 K | 292 K | |
| Net Income Applicable To Common Shares | 9.2 M | 9.7 M |
Aptevo Therapeutics Quarterly Net Working Capital |
|
Aptevo Therapeutics Stock Technical Analysis
Aptevo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Aptevo Therapeutics Period Price Range
Low | December 3, 2024
| High |
0.00 | 0.00 |
Aptevo Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Aptevo Therapeutics December 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Aptevo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aptevo Therapeutics shares will generate the highest return on investment. By undertsting and applying Aptevo Therapeutics stock market strength indicators, traders can identify Aptevo Therapeutics entry and exit signals to maximize returns
Aptevo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aptevo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aptevo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aptevo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0331 | |||
| Jensen Alpha | 0.4039 | |||
| Total Risk Alpha | (1.44) | |||
| Sortino Ratio | 0.021 | |||
| Treynor Ratio | (1.04) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptevo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptevo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.24) | Quarterly Revenue Growth (1.00) | Return On Assets (0.73) | Return On Equity (2.51) |
The market value of Aptevo Therapeutics is measured differently than its book value, which is the value of Aptevo that is recorded on the company's balance sheet. Investors also form their own opinion of Aptevo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aptevo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptevo Therapeutics' market value can be influenced by many factors that don't directly affect Aptevo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptevo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptevo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptevo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.